Products
Services
Applications
Resources Get started
Resource Centre
Back

Applying rapid whole-genome sequencing to predict phenotypic antimicrobial susceptibility testing results among carbapenem-resistant Klebsiella pneumoniae clinical isolates

Publication

Date: 21st December 2018 | Source: Antimicrobial Agents and Chemotherapy

Authors: Pranita D. Tamma, Yunfan Fan, Yehudit Bergman, Geo Pertea, Abida Q. Kazmi, Shawna Lewis, Karen C. Carroll, Michael C. Schatz, Winston Timp, Patricia J. Simner.

Standard antimicrobial susceptibility testing (AST) approaches lead to delays in the selection of optimal antimicrobial therapy. Here, we sought to determine the accuracy of antimicrobial resistance (AMR) determinants identified by nanopore whole-genome sequencing in predicting AST results. Using a cohort of 40 clinical isolates (21 carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae, 10 non-carbapenemase-producing carbapenem-resistant K. pneumoniae, and 9 carbapenem-susceptible K. pneumoniae isolates), three separate sequencing and analysis pipelines were performed, as follows: (i) a real-time nanopore analysis approach identifying acquired AMR genes, (ii) an assembly-based nanopore approach identifying acquired AMR genes and chromosomal mutations, and (iii) an approach using short-read correction of nanopore assemblies. The short-read correction of nanopore assemblies served as the reference standard to determine the accuracy of nanopore sequencing results. With the real-time analysis approach, full annotation of acquired AMR genes occurred within 8 h from subcultured isolates. Assemblies sufficient for full resistance gene and single-nucleotide polymorphism annotation were available within 14 h from subcultured isolates. The overall agreement of genotypic results and anticipated AST results for the 40 K. pneumoniae isolates was 77% (range, 30% to 100%) and 92% (range, 80% to 100%) for the real-time approach and the assembly approach, respectively. Evaluating the patients contributing the 40 isolates, the real-time approach and assembly approach could shorten the median time to effective antibiotic therapy by 20 h and 26 h, respectively, compared to standard AST. Nanopore sequencing offers a rapid approach to both accurately identify resistance mechanisms and to predict AST results for K. pneumoniae isolates. Bioinformatics improvements enabling real-time alignment, coupled with rapid extraction and library preparation, will further enhance the accuracy and workflow of the nanopore real-time approach.

Read the full text

Recommended for you

Open a chat to talk to our sales team
Subscribe

Subscribe

FAQs

FAQs

Search